Tumour suppressor gene dbccr1 at 9q32-33
CA 2288235 A1 · Owner: Habuchi, Tomonori · Inventors: Knowles, Margaret; Habuchi, Tomonori
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The application relates to the identification of a tumour suppressor locus at 9q32-33, and a gene within this region is disclosed. The gene is called "DBCCR1" for <u>D</u>eleted in <u>B</u>ladder <u>C</u>ancer <u>C</u>hromosome <u>R</u>egion candidate 1. The application further relates to uses of these findings, in particular in the diagnostic prophylactic and therapeutic , treatment of cancer especially bladder cancer. In particular some forms of , cancer are linked to hypermethylation based silencing of the DBCCR1 promoter or gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.